HR 2557
115th Congress
House
Health
Cancer
Genetics
Government information and archives
Health information and medical records
Medical tests and diagnostic methods
Medicare
Prostate Cancer Misdiagnosis Elimination Act of 2017
Introduced: May 19, 2017
See on congress.gov
Everywhere this bill has been
11 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 6, 2017
Placed on the Union Calendar, Calendar No. 331.
Dec 6, 2017
Committee on Ways and Means discharged.
Dec 6, 2017
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-449, Part I.
Oct 4, 2017
Ordered to be Reported (Amended) by Voice Vote.
Oct 4, 2017
Committee Consideration and Mark-up Session Held.
Sep 13, 2017
Forwarded by Subcommittee to Full Committee by Voice Vote .
Sep 13, 2017
Subcommittee Consideration and Mark-up Session Held.
Jun 1, 2017
Referred to the Subcommittee on Health.
May 26, 2017
Referred to the Subcommittee on Health.
May 19, 2017
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
May 19, 2017
Introduced in House
Plain-English summary
Prostate Cancer Misdiagnosis Elimination Act of 2017
This bill provides for Medicare coverage of a DNA Specimen Provenance Assay clinical diagnostic laboratory test following a positive prostate cancer biopsy.
What's happening now
Placed on the Union Calendar, Calendar No. 331.
Committees of jurisdiction
4
Cosponsors
1